logo
Hepatitis B vaccine – do we need boosters?
In vivo immunization following virus suppression
Lower expression of CD81 B-cell receptor in lymphoproliferative diseases associated with hepatitis C virus infection
The rate of fibrosis progression is an independent predictor of the response to antiviral therapy in chronic hepatitis C
The long-term efficacy of plasma-derived hepatitis B vaccine in babies born to carrier mothers
Adoptive transfer of donor-derived immunity by liver transplantation
Early viral kinetics on treatment with pegylated interferon-α-2a in chronic hepatitis C virus genotype 1 infection*
First phase hepatitis c viral kinetics in previous nonresponders patients
Comparative effects of adefovir and selected nucleoside inhibitors of hepatitis B virus DNA polymerase on mitochondrial DNA in liver and skeletal muscle cells
The safety and tolerability of daily infergen plus ribavirin in the treatment of naíïve chronic hepatitis C patients
Aetiology, clinical course and outcome of sporadic acute viral hepatitis in pregnancy*
Targeted destruction of the polymerized human serum albumin binding site within the preS2 region of the HBV surface antigen while retaining full immunogenicity for this epitope